Bicycle Therapeutics (BCYC) News
NASDAQ: BCYCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.89+0.08 (+2.10%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BCYC news summary
We found 1 recent headline mentioning Bicycle Therapeutics (BCYC): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, BCYC is up 2.10% at $3.89. The most recent story, "Kymera Appoints Felix Baker As Board Chairman, Succeeds Bruce Booth", was published by Nasdaq on Jun 25, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology